Treatment Preferences of Patients with Relapsed or Refractory Multiple Myeloma (RRMM) in the United States, United Kingdom, France, Spain, Italy, and Germany: Results from a Discrete Choice Experiment
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7211-7213
10.1182/blood-2022-164795